GHK-Cu

Most anti-aging ingredients come with extravagant promises and modest science. GHK-Cu is the opposite. It has decades of serious research behind it, a remarkable range of biological effects, and until recently it has largely flown under the mainstream radar.

That is starting to change. As longevity science has moved from the fringe toward the mainstream, GHK-Cu has attracted increasing attention from researchers, clinicians and biohackers who recognise that its effects extend well beyond skin deep.

This article covers what GHK-Cu actually is, how it works, what the research shows and why it deserves a place in the anti-aging conversation.

What Is GHK-Cu?

GHK-Cu stands for Glycine-Histidine-Lysine Copper. It is a naturally occurring tripeptide (three amino acids: glycine, histidine and lysine) that binds to copper ions. The resulting complex, GHK bound to copper (Cu), is the active form responsible for the biological effects described in the research.

GHK-Cu was first identified in human plasma in 1973 by Dr Loren Pickart, who noticed that young human plasma caused older liver tissue to function more like younger liver tissue. The active component driving this effect turned out to be GHK-Cu.

Naturally occurring GHK-Cu concentrations in the body are highest in young adults and decline significantly with age. At age 20, circulating plasma levels are typically around 200 nanograms per millilitre. By age 60, this has fallen to around 80 nanograms per millilitre. This age-related decline tracks closely with the deterioration in tissue repair capacity, wound healing and skin quality that characterises biological aging, which is not a coincidence.

What Does GHK-Cu Actually Do?

The breadth of GHK-Cu's effects is one of the most striking things about this compound. Rather than working through a single mechanism, it appears to act as a broad biological signal for tissue renewal and maintenance. Research has documented effects across several domains.

Collagen and connective tissue synthesis
GHK-Cu stimulates the production of collagen, elastin and the proteoglycans (such as hyaluronic acid) that make up the extracellular matrix of skin and connective tissue. In clinical research on skin, topical GHK-Cu has demonstrated measurable increases in skin thickness, density and firmness. It also activates enzymes responsible for breaking down damaged collagen, which is important because accumulated disorganised collagen contributes to skin aging. GHK-Cu supports both the removal of old, dysfunctional tissue and the construction of new, organised tissue.

Wound healing and tissue repair
GHK-Cu has been studied as a wound-healing compound since the 1980s. Research has demonstrated accelerated wound closure, improved tensile strength of repaired tissue and enhanced angiogenesis at wound sites. These effects overlap significantly with the healing peptides discussed in our recovery articles, highlighting that the mechanisms involved in tissue repair and those involved in anti-aging are often the same biology viewed from different angles.

Antioxidant and anti-inflammatory effects
GHK-Cu has demonstrated significant antioxidant activity, reducing oxidative stress in tissues. Oxidative stress is one of the primary drivers of cellular aging and age-related tissue damage. GHK-Cu also has anti-inflammatory properties, suppressing several pro-inflammatory signalling molecules associated with chronic, low-grade inflammation, sometimes called "inflammaging," which is increasingly recognised as a central feature of biological aging.

Gene expression modulation
This is perhaps the most scientifically remarkable aspect of GHK-Cu. Research by Dr Pickart and others has shown that GHK-Cu modulates the expression of over 4,000 human genes. Among the most significant findings are that it upregulates genes associated with tissue repair and maintenance while downregulating genes associated with cancer progression, inflammation and oxidative damage. A compound that can influence gene expression at this scale from a naturally occurring tripeptide is extraordinary from a research perspective.

Nervous system effects
More recent research has identified GHK-Cu's effects on nerve tissue regeneration, including promoting the growth of nerve fibres and improving outcomes in animal models of nerve injury. There is also emerging research on its potential neuroprotective effects relevant to cognitive aging, though this area requires further human research.

GHK-Cu and Skin: What the Clinical Evidence Shows

While GHK-Cu's broader biological effects are compelling, the most developed body of human clinical evidence relates to skin aging. Several double-blind, placebo-controlled studies have examined its effects as a topical treatment:

Research has shown measurable improvements in skin laxity, clarity, firmness and the appearance of fine lines and wrinkles after consistent use of GHK-Cu-containing formulations. These results are not anecdotal. They come from properly controlled clinical trials using objective measures of skin quality.

In one study comparing GHK-Cu to vitamin C and retinoic acid (vitamin A), GHK-Cu performed comparably on several measures of skin improvement, which is a meaningful benchmark given that retinoids are among the most clinically established anti-aging skin ingredients available.

Topical vs Systemic Administration

GHK-Cu is used in two distinct ways in research and practice.

Topical application
This is the most widely accessible form. Skincare products containing GHK-Cu are increasingly available, and topical application has the most developed clinical evidence base. Penetration through the skin barrier is limited, which means topical GHK-Cu primarily exerts its effects on the skin and underlying dermis rather than systemically.

Subcutaneous injection
For systemic effects on tissue repair, gene expression and the broader anti-aging mechanisms described above, subcutaneous injection of GHK-Cu delivers the peptide directly into circulation. This is the approach more relevant to people using it as part of a longevity protocol rather than purely for skin improvement.

The two approaches are not mutually exclusive. Some people use topical GHK-Cu for skin-specific benefits while incorporating injectable GHK-Cu into a broader anti-aging protocol.

How GHK-Cu Fits Into a Longevity Protocol

GHK-Cu's gene expression modulation, antioxidant activity and tissue renewal signals make it a logical component of a comprehensive anti-aging protocol. It is often combined with other longevity compounds:

With Epithalon, which targets telomere maintenance through a different mechanism, GHK-Cu's focus on active tissue renewal and gene expression creates a complementary approach.

With NAD+ precursors, which address cellular energy and DNA repair, GHK-Cu adds the tissue signalling and anti-inflammatory component.

For skin-focused protocols specifically, GHK-Cu is frequently paired with collagen-stimulating interventions and compounds that address oxidative stress.

Dosing Considerations

For subcutaneous use, typical research dosing ranges from 1 to 3mg per day, often administered in cycles of four to eight weeks. Topical products are applied according to product-specific guidance, with most serums and creams formulated at concentrations between 1% and 5%.

GHK-Cu has an excellent safety profile. As a naturally occurring compound present in all humans, adverse effects are uncommon and typically mild. Mild skin reactions at injection sites and temporary flushing have been reported in some cases.

Disclaimer: The information in this article is for educational purposes only. STRIATA peptides are research compounds and are not approved medicines. Always consult a qualified healthcare professional before beginning any protocol.